5 resultsfor “Louisiana lawsuit against FDA mifepristone”
FDA last October in an effort to prevent delivery of mifepristone. Louisiana argued that nationwide postage of the drug interfered with the state's own abortion ban. Earlier this month, in response to the lawsuit
lawsuit brought by the state of Louisiana, pauses a 2023 regulation from the Food and Drug Administration (FDA) that allowed doctors to send pills without seeing patients in person. "Every abortion facilitated by FDA
Louisiana appealed against the decision. Conservative lawmakers [expressed frustration](https://www.theguardian.com/us-news/2026/may/09/marty-makary-fda-food-drug-administration) with Marty Makary, the FDA commissioner who was [pushed out](https://www.theguardian.com/us-news/2026/may/12/marty-makary-fda-trump-administration) of the agency earlier this week. Former FDA leaders, researchers
mifepristone was medically unnecessary in 2021. The state of Louisiana sued the FDA last fall, arguing that telemedicine access undermines the state's abortion ban. [![Misoprostol is typically used as part of a two-drug
FDA's gold-standard, science-based drug approval system." ### **4. The patients most affected by the case** During pregnancy, days and hours matter. The uncertainty around the availability of this medication has sent "shockwaves" through